Jason Evans, MD
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $15,000 of the $21,238 with a category attached, or 70.6%. Calyxo, Inc. accounts for 71.5% of it on its own, with 39 other manufacturers making up the rest. 2025 is the largest year on record at $16,082, more than ten times the $1,478 reported in 2019. Among urology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 262 payments — averaging $81.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Calyxo, Inc.$15K
- AbbVie$960
- Neotract Inc.$881
- Valencia Technologies Corporation$865
- Astellas Pharma US Inc$425
- Teleflex LLC$382
- plus $3K from 34 others
What the payments were for
- Royalty or licence$15,00071%
- Travel & lodging$1,3506%
- Food & beverage$4,84723%
- Education$400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CVAC Aspiration System$15,106
- eCoin Device Kit$784
- UroLift$678
- Barrigel$191
How this compares
$21,238 in reported general payments places this provider in the 90th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 68 | $60,456 |
| GemtesaVibegron | 19 | $22,757 |
| Mirabegron ErMirabegron | 30 | $14,868 |
| Tamsulosin Hcl | 574 | $12,245 |
| Finasteride | 454 | $10,542 |
| Methenamine Hippurate | 80 | $9,069 |
| Trospium Chloride ErTrospium Chloride | 25 | $6,770 |
| Potassium Citrate ErPotassium Citrate | 53 | $5,520 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 130 | $4,788 |
| Trospium Chloride | 92 | $3,769 |
| Dutasteride-TamsulosinDutasteride/Tamsulosin Hcl | 11 | $2,871 |
| Oxybutynin Chloride ErOxybutynin Chloride | 112 | $2,736 |
| Testosterone | 27 | $2,677 |
| NitrofurantoinNitrofurantoin Macrocrystal | 124 | $2,641 |
| Tolterodine Tartrate ErTolterodine Tartrate | 31 | $2,060 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $425 | $60,45668 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $18 | $22,75719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 400 urology providers in Michigan.
Other urology in Flint
- Ashok ReddySterling Heights$4.9M
- William RobertsAnn Arbor$973K
- Kenneth KernenTroy$910K
- William JohnstonLivonia$675K
- Jason HafronWest Bloomfield$490K
- Khurshid GhaniAnn Arbor$413K
- Richard BennettRoyal Oak$361K
- Ryan NelsonUtica$296K
- Casey DauwAnn Arbor$188K
- Aram LoebDetroit$112K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.